Cached score snapshot

US.VRTX · Vertex Pharmaceuticals

110分制 58.1/110;5D動能v2 15/50;排序分 73.1/160

Ranking score 73.1/160
Main score 58.1/110
5D momentum v2 15/50
Rank #16
Setup grade D 40.6

Score breakdown

觀望

Medium database-backfill

Score and price trend

D 40.6 Technical A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 01-02 02-19 04-07 05-21 07-08 $379.57$475.27$570.97 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.36 · anchors 120 +0.74% -0.98% / +2.21% 60% 7.5% Actual -5.34% · vs median -6.08% · inside 25-75 band
30D observation -1.00% -9.74% / +6.14% 47.5% 35% Actual -11.63% · vs median -10.63% · inside 25-75 band
Historical projection 10D n=160 +0.33% -1.94% / +2.16% 53.8% 9.4% Actual -7.60% · vs median -7.93% · inside 25-75 band

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-01-02 → 2026-07-08 · 128 archived points · 1 Improving turn signal · 4 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 73.1
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 58.1/110 (觀望)
5D momentum v2 15/50 (弱)
Score with momentum v2 73.1/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 4 sections

Market inputs

Bar count 178
ma20 477.405
ma50 468.795
close 492.38
prevClose 499.17
avgVolume20 1529755
volumeRatio 1.35
changePercent -1.36

Metrics snapshot

close 492.38
volume 2062300
changePercent -1.36

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 58.1/110
Main rating 觀望
5D momentum v2 15/50
Score with momentum v2 73.1/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.8/5 · 良好

Dimension score 3.8/5
Dimension grade 良好

No sub-item breakdown recorded.

資金流 — 11.6/20 · 較差

Dimension score 11.6/20
Dimension grade 較差

No sub-item breakdown recorded.

市場環境 — 6.2/15 · 較差

Dimension score 6.2/15
Dimension grade 較差

No sub-item breakdown recorded.

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

No sub-item breakdown recorded.

風險管理 — 6.9/10 · 一般

Dimension score 6.9/10
Dimension grade 一般

No sub-item breakdown recorded.

技術信號 — 23.6/30 · 良好

Dimension score 23.6/30
Dimension grade 良好

No sub-item breakdown recorded.

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

No sub-item breakdown recorded.

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 15/50
ret_5d 0.0303
raw_total 15
vcp_bonus 0
ret_points 8
vol_points 4
breakout_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.5

details

atrPct 3.1369
turnoverUsdM 1015.4353
liquidityPoints 0.8
volatilityPoints 0.7
rrPoints 1.6

stopLevels

symbol US.VRTX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 461.4886

strength_details

ma_score 2
atr_score 1
rsi_score 2
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.5
stop_loss_percent 6.3
take_profit_price 539.9528
target_multiplier 2.2
technical_strength 2.1
take_profit_percent 9.7
positionPoints 1.5
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.5461
stopLossPercent 6.2739
diversificationPoints 2

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.5,
      "details": {
        "atrPct": 3.1369470733985945,
        "turnoverUsdM": 1015.435274,
        "liquidityPoints": 0.8,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.VRTX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 461.4886,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.5,
      "stop_loss_percent": 6.3,
      "take_profit_price": 539.9528,
      "target_multiplier": 2.2,
      "technical_strength": 2.1,
      "take_profit_percent": 9.7
    },
    "positionPoints": 1.5,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.5460892028202022,
    "stopLossPercent": 6.273894146797189,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 73.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 15
  },
  "market": {
    "ma20": 477.405,
    "ma50": 468.795,
    "close": 492.38,
    "prevClose": 499.17,
    "avgVolume20": 1529755,
    "volumeRatio": 1.35,
    "changePercent": -1.36
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred+database-backfill-market-proxy"
  },
  "barCount": 178,
  "momentum": {
    "max": 50,
    "result": 15,
    "details": {
      "ret_5d": 0.030320763558125075,
      "raw_total": 15,
      "vcp_bonus": 0,
      "ret_points": 8,
      "vol_points": 4,
      "breakout_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.1,
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.8,
      "資金流": 11.6,
      "市場環境": 6.2,
      "情緒分析": 4,
      "技術信號": 23.6,
      "風險管理": 6.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差"
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差"
      },
      "市場環境": {
        "max": 15,
        "grade": "較差"
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差"
      },
      "技術信號": {
        "max": 30,
        "grade": "良好"
      },
      "風險管理": {
        "max": 10,
        "grade": "一般"
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ]
  }
}

Raw metrics JSON

{
  "close": 492.38,
  "volume": 2062300,
  "changePercent": -1.36
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.